Wolverine Asset Management
GOSS icon

Wolverine Asset Management’s Gossamer Bio GOSS Stock Holding History

Wolverine Asset Management’s Portfolio GOSS Stock Details GOSS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		– Sell
-161,184
Closed -$2.12M – 1795
2026
Q2 		$2.12M Buy
+161,184
New +$3.6M 0.02% 589

Other funds holding GOSS

Context Capital Management
Context Capital Management Lajolla, California $4.89B AUM 1.86% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.32T AUM 44.66% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
Squarepoint
Squarepoint New York $90.8B AUM 26.98% 1-Year Est. Return
MB Generational Wealth
MB Generational Wealth Spokane, Washington $196M AUM 14.53% 1-Year Est. Return
Monaco Asset Management
Monaco Asset Management Monaco $818M AUM 32.61% 1-Year Est. Return
Hennion & Walsh Asset Management
Hennion & Walsh Asset Management Parsippany, New Jersey $3.42B AUM 25.82% 1-Year Est. Return
Citigroup
Citigroup New York $308B AUM 40.94% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $85.7B AUM 51.02% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $362B AUM 34.89% 1-Year Est. Return

Wolverine Asset Management's GOSS Position: Q3 2026 in Review

Wolverine Asset Management sold out of Gossamer Bio (GOSS) in Q3 2026, closing a stake of 161,184 shares — an estimated $2.12M sold.

Wolverine Asset Management first reported a position in GOSS in Q2 2026 and held it in 1 quarter. The position peaked at $2.12M in Q2 2026. 24 funds tracked by Wall St. Rank hold GOSS as of Q3 2026.

  • Wolverine Asset Management reported no remaining Gossamer Bio position as of Q3 2026 after selling out during the quarter.
  • Wolverine Asset Management sold 161,184 Gossamer Bio shares in Q3 2026, an estimated $2.12M.
  • Wolverine Asset Management first reported a position in Gossamer Bio in Q2 2026 and held it in 1 quarter.
  • Wolverine Asset Management's Gossamer Bio position peaked at $2.12M in Q2 2026.
  • 24 funds tracked by Wall St. Rank held Gossamer Bio as of Q3 2026.

Based on Wolverine Asset Management's 13F filing for Q3 2026, filed 2 Nov 2026.